FDA approves Bristol-Myers' Opdivo for small cell lung cancer
August 17, 2018 at 08:03 AM EDT
Bristol-Myers Squibb Co said on Friday the U.S. Food and Drug Administration approved its treatment, Opdivo, for patients whose lung cancer had progressed even after undergoing chemotherapy and at least one other therapy.
